Bio-Rad Laboratories (BIO) Tax Provisions (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Tax Provisions data on file, last reported at -$162.7 million in Q1 2026.

• Tax Provisions for Q1 2026 came in at -$162.7 million, down 938.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.5 million (up 109.13% YoY), and the FY2025 annual result was $235.6 million, up 147.28% from the prior year.
• Tax Provisions declined to -$162.7 million in Q1 2026 per BIO's latest filing, from $209.2 million in the prior quarter.
• Over five years, Tax Provisions peaked at $263.6 million in Q4 2022 and troughed at -$1.0 billion in Q1 2022.
• A 5-year average of -$100.9 million and a median of $15.9 million in 2023 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2024 and 2026: Tax Provisions surged 575.64% in 2024, then tumbled 938.66% in 2026.
• A 5-year view of Tax Provisions shows it stood at $263.6 million in 2022, then slumped by 70.16% to $78.7 million in 2023, then tumbled by 345.47% to -$193.1 million in 2024, then surged by 208.34% to $209.2 million in 2025, then sank by 177.77% to -$162.7 million in 2026.
• Business Quant data shows BIO's Tax Provisions at -$162.7 million in Q1 2026, $209.2 million in Q4 2025, and -$89.2 million in Q3 2025.